(Q34914210)

5 August 2017

1 reference

title

Endocrine complications in pediatric patients with acute lymphoblastic leukemia (English)

1 reference

5 August 2017

1 reference

lymphoblastic leukemia

1 reference

2

Ching-Hon Pui

1 reference

5 August 2017

Scott C Howard

1

1 reference

5 August 2017

1 December 2002

1 reference

5 August 2017

1 reference

5 August 2017

16

1 reference

5 August 2017

4

1 reference

5 August 2017

225-243

1 reference

Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type.

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Disturbance of pubertal development after cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Testicular function following chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Reproduction post-chemotherapy in young cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone: analysis of the MRC AML 10 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Endocrine complications of bone marrow transplantation in children

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Longitudinal gonadal function after bone marrow transplantation for acute lymphoblastic leukemia during childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Reproductive and endocrine gonadal functions in adults following multidrug chemotherapy for acute lymphoblastic or undifferentiated leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Reproduction following treatment for childhood leukemia: a population-based prospective cohort study of fertility and offspring

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Endocrine complications of neoplastic diseases in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Abnormal growth patterns and adult short stature in 115 long-term survivors of childhood leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Influence of treatment modalities on prepubertal growth in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

A longitudinal study of growth and growth hormone secretion in children during treatment for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Longitudinal growth in children with non-Hodgkin's lymphoma and children with acute lymphoblastic leukemia: comparison between unirradiated and irradiated patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Long-term effects of treatment for acute lymphoblastic leukemia with and without cranial irradiation on growth and puberty: a comparative study.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Influence of Treatment Modalities on Prepubertal Growth in Children with Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Modifications of Growth Velocity and the Insulin-Like Growth Factor System in Children with Acute Lymphoblastic Leukemia: A Longitudinal Study

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Factors contributing to the impairment of growth in children with acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Final attained height in patients successfully treated for childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Growth in children treated for acute lymphoblastic leukemia with and without prophylactic cranial irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Insulin-like growth factor-I and insulin-like growth factor binding protein-3 during maintenance chemotherapy of acute lymphoblastic leukemia in children

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Final height after treatment for childhood acute lymphoblastic leukemia: comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Anthropometric parameters and their relationship to serum growth hormone-binding protein and leptin levels in children with acute lymphoblastic leukemia: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Effects of a third intensification block of chemotherapy on bone and collagen turnover, insulin-like growth factor I, its binding proteins and short-term growth in children with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Subnormal growth during puberty in children treated for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Growth failure and growth-hormone deficiency after treatment for acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Growth and growth hormone secretion after treatment for acute lymphoblastic leukemia in childhood. 18-Gy versus 24-Gy cranial irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Pulsatile growth hormone secretion in children with acute lymphoblastic leukemia after 1800 cGy cranial radiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Height and weight pattern up to 20 years after treatment for acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Human growth hormone (HGH) levels at diagnosis of acute lymphoblastic leukemia (ALL)

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Leukemia in a patient treated with growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Risk of leukemia in children treated with human growth hormone: review and reanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Relationship of growth hormone deficiency and leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Leukemia in Growth-Hormone Treated Patients: An Update, 1992

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Growth hormone replacement therapy in children with leukemia in remission

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Body composition of long-term survivors of acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Obesity after successful treatment of acute lymphoblastic leukemia in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Hyperleptinaemia in young adults following cranial irradiation in childhood: growth hormone deficiency or leptin insensitivity?

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

1 reference

7 January 2021

Clinical epidemiology and osteoporosis. Measures and their interpretation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

The pathogenesis of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Osteoporosis as a pediatric problem

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Calcium and peak bone mass

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Factors that influence peak bone mass formation: a study of calcium balance and the inheritance of bone mass in adolescent females

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Determinants of peak bone mass and mechanisms of bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

1 reference

7 January 2021

Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Characteristics of acute lymphoblastic leukemia in children with osteopenia and vertebral compression fractures

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Bony morbidity in children treated for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Spontaneous humerus fracture and osteoporosis: an unusual initial presentation of acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Vertebral compression and eosinophilia in a child with acute lymphatic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Corticosteroid osteoporosis: practical implications of recent trials

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Corticosteroid osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

1 reference

7 January 2021

Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Osteopenia in young adult survivors of childhood cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Bone mineral density in young adult survivors of childhood cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Relative osteopenia after treatment for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Bone mass after treatment for acute lymphoblastic leukemia in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Osteoporosis after cranial irradiation for acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Longitudinal evaluation of bone mineral density in children receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Prevention of glucocorticoid induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Corticosteroid osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Corticosteroid osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Minimizing complications from systemic glucocorticosteroid use.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Drug-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Bone mass after treatment for acute lymphoblastic leukemia in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Normal bone mineral density after treatment for childhood acute lymphoblastic leukemia diagnosed between 1991 and 1998

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Vertebral compression fracture as a presenting feature of acute lymphoblastic leukemia in children

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Bone mineral content in black pre-schoolers: normative data using single photon absorptiometry

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Comparison between broad-band ultrasound attenuation of the calcaneum and total body bone mineral density in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Comparison of quantitative ultrasound measurements in calcaneus with DXA and SXA at other skeletal sites: a population-based study on 280 children aged 11-16 years

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Bone mass in healthy children: measurement with quantitative DXA.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Bone densitometry in Canadian children 8-17 years of Age.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Measurement of volumetric bone mineral density accurately determines degree of lumbar undermineralization in children with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Evaluation of low density spine software for the assessment of bone mineral density in children

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Total-body and regional bone mineral content and areal bone mineral density in children aged 8-18 y: the Fels Longitudinal Study

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Peak bone mineral accrual and age at menarche in adolescent girls: a 6-year longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Bone mineral status in prepubertal children with constitutional delay of growth and puberty

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Type of physical activity, muscle strength, and pubertal stage as determinants of bone mineral density and bone area in adolescent boys

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Bone mineral density in children and adolescents: relation to puberty, calcium intake, and physical activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Osteopenia in children surviving brain tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Bone mineral density in survivors of cancer in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

The spectrum of metabolic bone disease in lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Effects of Intensive Chemotherapy on Bone and Collagen Turnover and the Growth Hormone Axis in Children with Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Bone metabolism and mineralisation after cytotoxic chemotherapy including ifosfamide

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Whole body bone mineral content in healthy children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

[The property of calcium in the child and the adolescent: importance in the acquisition of bone mineral density]

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Milk intake and bone mineral acquisition in adolescent girls. Increases in bone density may be result of micronutrients in additional cereal

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

The effect of dietary calcium intake on bone mineral density in healthy adolescent girls and young women in southern Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Dietary calcium, protein, and phosphorus are related to bone mineral density and content in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Adolescent nutrition in the prevention of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Mineral loss in cortical and trabecular bone during high-dose prednisone treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Influence of 1 alpha-(OH)D3 administration on bone and bone mineral metabolism in patients on chronic glucocorticoid treatment; a double blind controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Double-blind, controlled calcium supplementation and bone mineral accretion in children accustomed to a low-calcium diet.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Calcium supplements in the prevention of steroid-induced osteoporosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Urolithiasis in childhood acute leukemia and nonHodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Glucocorticoid-induced adrenal insufficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

The Effect of Long-Term Glucocorticoid Therapy on Pituitary–Adrenal Responses to Exogenous Corticotropin-Releasing Hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Hypothalamic-pituitary-adrenal axis suppression after short-term, high-dose glucocorticoid therapy in children with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Pituitary-adrenal responsiveness to corticotropin-releasing hormone in patients receiving chronic, alternate day glucocorticoid therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Time course of recovery of adrenal function in children treated for leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Adrenal suppression after short-term corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Primary adrenocortical insufficiency in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Treatment of adrenocortical insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Hyperkalaemia in acute leukaemia: a sign of adrenocortical insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Assessment of corticosteroid replacement therapy in adults with adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Tests of adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Cortisol production rate in childhood and adolescence.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Sepsis-induced adrenal deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Hypothalamic-pituitary-adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Addison's disease. Hydrocortisone should be started immediately adrenal insufficiency is considered

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

NATURAL HISTORY OF PITUITARY-ADRENAL RECOVERY FOLLOWING LONG-TERM SUPPRESSION WITH CORTICOSTEROIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Recovery of the hypothalamic-pituitary-adrenal (HPA) axis in patients with rheumatic diseases receiving low-dose prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Hyperglycemia associated with the therapeutic use of L-asparaginase: possible role of insulin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Diabetes in patients treated with asparaginase

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Attenuation of asparaginase-induced hyperglycemia after substitution of the Erwinia carotovora for the Escherichia coli enzyme preparation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Symptomatic hypoglycemia in children receiving oral purine analogues for treatment of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Fasting hypoglycemia is common during maintenance therapy for childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

REDUCED LIVER GLUCOSE-6-PHOSPHATASE IN HUMAN LEUKEMIA

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Co-operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Vincristine neurotoxicity and abnormal secretion of antidiuretic hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Syndrome of inappropriate secretion of antidiuretic hormone induced by paroxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Symptomatic syndrome of inappropriate antidiuretic hormone secretion associated with azithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Incidence of selective serotonin reuptake inhibitor (SSRI) induced hyponatraemia due to the syndrome of inappropriate antidiuretic hormone (SIADH) secretion in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Symptomatic syndrome of inappropriate antidiuretic hormone secretion associated with azithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Drug-induced syndrome of inappropriate antidiuretic hormone secretion. Causes, diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Severe hyponatremia due to syndrome of inappropriate secretion of antidiuretic hormone in a patient receiving interferon-alpha for chronic myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Syndrome of inappropriate antidiuretic hormone secretion induced by different drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Syndrome of inappropriate antidiuretic hormone secretion (SIADH) and enalapril

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Imipramine-induced syndrome of inappropriate antidiuretic hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Vincristine neurotoxicity with hyponatremia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Hyponatremia and vincristine therapy. Syndrome possibly resulting from inappropriate antidiuretic hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Syndrome of inappropriate secretion of antidiuretic hormone caused by vincristine therapy: a case report of the neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Vincristine-Induced Syndrome of Inappropriate Secretion of Antidiuretic Hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Syndrome of inappropriate secretion of antidiuretic hormone produced by vincristine toxicity (with bioassay of ADH level).

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Inappropriate secretion of antidiuretic hormone secondary to vincristine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Severe vincristine toxicity in combination with itraconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

The role of antidiuretic hormone in hyponatremia in adrenal insufficiency--is the guideline for the diagnosis of syndrome of inappropriate secretion of the antidiuretic hormone appropriate?

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Hyponatremia and osmoregulation of thirst and vasopressin secretion in patients with adrenal insufficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion with convulsions, coma and pulmonary oedema in a patient using paroxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Comatose state due to severe hyponatremia in a patient with the syndrome of inappropriate antidiuretic hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Sudden death in two patients with epilepsy and the syndrome of inappropriate antidiuretic hormone secretion (SIADH)

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

The syndrome of inappropriate secretion of antidiuretic hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Delayed onset of central pontine myelinolysis despite appropriate correction of hyponatraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Central Pontine Myelinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Central pontine myelinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Thyroid function during L-asparaginase therapy in children with acute lymphoblastic leukemia: difference between induction and late intensification

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Thyroid function in children treated for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Thyroid function in children after cytostatic treatment for acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Thyroid function in survivors of childhood acute lymphoblastic leukaemia: the significance of prophylactic cranial irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Dosimetry of radiation scattered to thyroid gland from prophylactic cranial irradiation for childhood leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Radiation-induced hypopituitarism is dose-dependent

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Thyroid function in adrenocortical insufficiency during withdrawal and re-administration of glucocorticoid substitution

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Pilot studies of species-specific chemotherapy of childhood acute lymphoblastic leukemia using genotype and immunophenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991-1996).

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900042-5

7 January 2021

10.1016/S0268-960X(02)00042-5

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12350366